HCPCS Level II code L8600 identifies an implantable breast prosthesis made of silicone or an equivalent material. The code covers the prosthetic device itself, commonly used in breast reconstruction or augmentation procedures following mastectomy, trauma, or for cosmetic purposes. Nationally, implantable prostheses are material-cost drivers in surgical episodes and are subject to payer-specific coverage policies and coding guidance.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical clinical and site-of-service contexts, and an overview of the types of benchmarks and policy considerations that affect coverage and billing. The publication highlights common modifiers that accompany device billing, payer coverage patterns, and clinical scenarios where L8600 is used. It also outlines where additional documentation and coding clarity are typically required.

This summary serves clinicians, billing professionals, and policy analysts seeking a focused reference for the device code, reimbursement context, and practical implications for surgical supply management and claims processing.